Skip to Main Content

Paper Details

Healthcare utilization and costs associated with tyrosine kinase inhibitor switching in patients with chronic myeloid leukemia.
Leuk Lymphoma
4
2016
Author NameAffiliation
Patricia Kropfa Fox Chase Cancer Center
Jean-Pierre J Issac Fels Institute for Cancer Research , Temple University School of Medicine
  • 1 - 2

Datasets

Release 1.2